Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare Conference
07 July 2021 - 6:03AM
Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing
solutions for patients suffering from fluid overload, today
announced that, Nestor Jaramillo, Chief Executive officer, and
George Montague, Chief Financial Officer, are scheduled to
participate in the 2021 Ladenburg Thalmann Healthcare Conference on
Wednesday, July 14th, 2021.
Event: |
2021 Ladenburg
Thalmann Healthcare Conference |
|
|
Format: |
Presentation & Fireside Chat |
|
|
Date: |
Wednesday, July 14, 2021 |
|
|
Time: |
4:00 pm ET |
An audio webcast of the presentation will be available online at
the Nuwellis’ investor relations
website, https://ir.nuwellis.com. Additionally, a replay will
be available for 90 days after the presentation.
About NuwellisNuwellis, Inc. (Nasdaq: NUWE) is
a medical device company dedicated to transforming the lives of
patients suffering from fluid overload through science,
collaboration, and innovation. The company is focused on
developing, manufacturing, and commercializing the Aquadex
SmartFlow® system for ultrafiltration therapy. Nuwellis is a
Delaware corporation headquartered in Minneapolis, Minnesota with a
wholly owned subsidiary in Ireland. The company has been listed on
the Nasdaq Capital Market since February 2012.
About the Aquadex SmartFlow System The Aquadex
SmartFlow system delivers clinically proven therapy using a simple,
flexible and smart method of removing excess fluid from patients
suffering from hypervolemia (fluid overload). The Aquadex SmartFlow
system is indicated for temporary (up to 8 hours) or extended
(longer than 8 hours in patients who require hospitalization) use
in adult and pediatric patients weighing 20 kg or more whose fluid
overload is unresponsive to medical management, including
diuretics. All treatments must be administered by a health care
provider, within an outpatient or inpatient clinical setting, under
physician prescription, both having received training in
extracorporeal therapies.
CONTACTS
INVESTORS:Matt Basco, CFAGilmartin Group
LLCMatt.bacso@gilmartinir.com
MEDIA:Jessica
StebingHealth+Commerce260-336-6202jstebing@healthandcommerce.com
Newellis (NASDAQ:NUWE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Newellis (NASDAQ:NUWE)
Historical Stock Chart
From Jul 2023 to Jul 2024